08/05/2026
Kilifi County Charges Forward in HIV Prevention with Landmark Launch of Long-Acting PrEP (Lenacapavir)
KILIFI, KENYA – In a decisive move to turn the tide against HIV, the Kilifi County Department of Health, in partnership with The LVCT Health-Stawisha Pwani project, supported by the U.S. Department of State, has officially debuted Lenacapavir (LEN), a game-changing, long-acting injectable PrEP that brings us one step closer to an HIV-free generation. Administered only twice a year, this breakthrough medication is set to redefine the national prevention landscape.
The urgency of this intervention was underscored by James Nzola, HTS & PrEP Specialist at LVCT Health- Stawisha Pwani, who revealed that 983 new infections were recorded in Kilifi County over the last seven months alone in 131 health facilities supported by the Stawisha Pwani project. To combat this, the county has already received an initial 1,096 doses of Lenacapavir. The response has been immediate and encouraging: 406 doses have already been administered to high-priority groups, including pregnant and breastfeeding mothers, young people, and populations at increased risk.
A GAME-CHANGER IN THE FIGHT
Catherine Munywoki, Head of Preventive and Promotive Health Services in Kilifi, hailed Lenacapavir as a game-changer for those who find daily pill adherence a challenge. She called for a united front between implementing partners, the National Government, Division of National AIDS and STI Control Program, and NSDCC. "Our goal is the total reduction of HIV infections. With this long-term injectable, we finally have the technology to outpace the epidemic," she noted.
THE SPRINT TO 2030
While offering her remarks during the launch, Patriciah Jeckonia, LVCT Health’s Program Manager for Policy Advocacy and HIV Technologies, issued a stirring clarion call to stakeholders, including the Community Health Promoters (CHPs), Implementing Partners, and County and National Government health officers. She characterized the mission as a sprint race to meet the national target of reducing new infections to below 1,000 by 2030. “We must be aggressive in our advocacy and compassionate in our delivery,” Jeckonia urged, while challenging the community to dismantle the walls of stigma. “Taking PrEP is an act of responsibility. We must support those protecting their health if we are to win this race.”
The launch was attended by other key stakeholders, including the Kenya Red Cross, MEWA, TIMIZA, AMKENI, EMPOWERNET, and TIKO, all pledging to integrate Lenacapavir into their nationwide outreach efforts.
📢 CALL TO ACTION: A NATIONAL SPRINT
The tools to end HIV are now in our hands, but technology alone is not enough, we need a national movement. We call on every health worker and community leader to champion this new era of twice-yearly injectable PrEP as we sprint toward our 2030 targets. To every Kenyan, knowledge is power: visit your nearest facility to see how this breakthrough can protect your future. Now is the time to replace stigma with solidarity and judgment with action. Let’s lead the continent in ending new infections—not just in one county, but across the entire Republic.
The race is on; get informed, get protected, and let’s finish the fight together. The Ministry of Health Division of National AIDS and STI Control Program NSDCC The Global Fund World Health Organization (WHO) U.S. Department of State